NCT02856854View on ClinicalTrials.gov

A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 17, 2017

Study Completion Date

July 25, 2017

Conditions
Cocaine Use Disorder
Interventions
DRUG

EMB-001

EMB-001 is a combination of metyrapone (720mg per dose in this study) and oxazepam (24mg per dose in this study)

DRUG

Placebo

EMB-001 matched placebo

DRUG

Cocaine IV

Cocaine administered at doses of 20 and 40mg

DRUG

Saline IV

Cocaine matched placebo

Trial Locations (1)

66212

Vince & Associates, Overland Park

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Embera NeuroTherapeutics, Inc.

INDUSTRY